PD-217,014

DRUG2 trials

Sponsors

Pfizer

Conditions

Irritable Bowel SyndromePain

Phase 2

A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.

CompletedNCT00139672

PfizerIrritable Bowel Syndrome

Start: 2004-01-31End: 2005-02-28Target: 330Updated: 2008-06-17

Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia

TerminatedNCT00159640

Start: 2004-02-29Target: 315Updated: 2007-03-28